Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: Czechia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20171
20181
20193
20204
20213
20223
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Merck Sharp & Dohme LLC3
Daiichi Sankyo2
Eli Lilly and Company2
AbbVie1
Bristol-Myers Squibb1
Dizal Pharmaceuticals1
EMD Serono Research & Development Institute, Inc.1
Janssen Research & Development, LLC1
Mirati Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung23
Neoplasm Metastasis4
Lung Neoplasms3
Neoplasms3
Ovarian Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Lung Diseases2
Pancreatic Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.